« EU approvals for Amgen’s drug Prolia (denosumab) | Main | May Recipe of Month »

05/31/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133ef5a9533970b

Listed below are links to weblogs that reference Comparative Value Proof - New Drugs, Biosimilars & Generics :

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

Roche does an excellent job among the leaders in biopharm to extend is novel drugs with valuable new technologies. Here it is applying SeaGen technology to extend its Rituxan and Herceptin franchises in a meaningful way.
http://seekingalpha.com/article/207677-seattle-genetics-leads-the-way-in-next-generation-antibody-technologies

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada